NCT00920374View on ClinicalTrials.gov

A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

June 16, 2009

Primary Completion Date

July 8, 2009

Study Completion Date

July 8, 2009

Conditions
Influenza
Interventions
BIOLOGICAL

Fluarix™/Influsplit SSW®

single intramuscular dose on Day 0

Trial Locations (5)

01097

GSK Investigational Site, Dresden

01099

GSK Investigational Site, Dresden

01129

GSK Investigational Site, Dresden

01307

GSK Investigational Site, Dresden

01705

GSK Investigational Site, Freital

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY